Browse Related Topics For:

Amgen

97
Biosimilars
86
BPCIA
65
Sandoz
65
Sandoz v Amgen
63
FDA
62
Patents
53
Pharmaceutical Patents
52
Patent Litigation
51
Patent Infringement
47
Pharmaceutical Industry
38
SCOTUS
30
Patent Dance
25
Biologics
24
Notice Requirements
23
FDA Approval
22
Preliminary Injunctions
21
Apotex
21
Class Action
18
Amgen Inc. v Connecticut Retirement Plans
18
Class Certification
17
Commercial Marketing
16
aBLA
16
Prescription Drugs
15
Popular
15
Securities Fraud
14
ERISA
14
Fraud-on-the-Market
12
Appeals
11
Biologics Price Competition and Innovation Act of 2009
11
Fiduciary Duty
11
Stock Drop Litigation
10
Declaratory Judgments
10
FIfth Third Bancorp v Dudenhoeffer
10
Generic Drugs
9
Petition for Writ of Certiorari
7
Employee Benefits
7
Healthcare
7
Hospira
7
Pleading Standards
7
Securities Litigation
6
Injunctive Relief
6
Rebuttable Presumptions
5
ANDA
5
Corporate Counsel
5
Hatch-Waxman
5
Inter Partes Review Proceedings
4
Biotechnology
4
Disclosure Requirements
4
Dismissals
4
Duty of Prudence
4
Halliburton
4
Injunctions
4
Motion to Dismiss
4
Patent Trial and Appeal Board
4
Public Health Service Act
4
Unfair Competition
3
401k
3
Actavis Inc.
3
Affordable Care Act
3
AstraZeneca
3
Breach of Duty
3
Citizen Petitions
3
Conversion
3
En Banc Review
3
ESOP
3
Failure To State A Claim
3
IP License
3
Janssen Pharmaceuticals
3
Oral Argument
3
Patent Applications
3
Petition For Rehearing
3
Retirement Plan
3
SEC
3
Securities
3
Solicitor General
2
Advisory Committee
2
American Express v Italian Colors Restaurant
2
Amicus Briefs
2
Arbitration
2
Basic v Levinson
2
CAFA
2
Certiorari
2
Class Action Arbitration Waivers
2
Counterclaims
2
Declaratory Relief
2
Disclosure
2
Discovery
2
Dispute Resolution
2
EU
2
Fraud
2
Gabelli v SEC
2
Halliburton v Erica P. John Fund
2
Inside Information
2
Life Sciences
2
Loss Causation
2
Material Misstatements
2
Materiality
2
Medicaid
2
Medicare
2
Mootness
2
Orange Book
2
Oxford Health v Sutter
2
Pre-Market Notification
2
Preemption
2
Safe Harbors
2
Securities Exchange Act
2
Standard Fire Ins. Co. v. Knowles
2
Statute of Limitations
2
Subject Matter Jurisdiction
2
Teva Pharmaceuticals
2
Wal-Mart
1
AbbVie
1
Administrative Procedure Act
1
Affirmative Action
1
Alien Tort Statute
1
Allergan v Sandoz
1
Already LLC
1
Amended Regulation
1
America Invents Act
1
American Express
1
AMP v Myriad
1
Anti-Kickback Statute
1
Article III
1
Bayer
1
Biogen Idec
1
Books & Records
1
Bowman v Monsanto
1
BPCI
1
Business Torts
1
Canning v NLRB
1
Certifications
1
CFTC
1
Chadbourne & Parke LLP v Troice
1
Citizen Suits
1
Civil Monetary Penalty
1
Claim Construction
1
Clinical Trials
1
Comcast
1
Comcast v. Behrend
1
Comment Period
1
Community Trademark
1
Conflict Mineral Rules
1
Contract Interpretation
1
Copyright
1
Corporate Governance
1
DaimlerChrysler
1
Damages
1
Declaratory Rulings
1
Defense Strategies
1
Defined Benefit Plans
1
Derivative Suit
1
Discovery Rule
1
DNA
1
Dukes v Wal-Mart
1
Exclusive Remedy
1
Exhaustion Doctrine
1
Expert Testimony
1
Extraterritoriality Rules
1
False Claims Act (FCA)
1
Federal Arbitration Act
1
Federal Rules of Civil Procedure
1
FEHA
1
Filing Fees
1
First Impression
1
First Sale Doctrine
1
Fisher v University of Texas
1
Frivolous Lawsuits
1
FTC v Actavis
1
Genetically Engineered Seed
1
GlaxoSmithKline
1
Health Insurance
1
Hoffman LaRoche
1
Hollingsworth v Perry
1
Hospitals
1
Human Genes
1
Information Sharing
1
Infringement
1
Innovator Liability
1
Insider Trading
1
Inventions
1
IRS
1
iTraxx CDS indices
1
Johnson & Johnson
1
Jurisdiction
1
Kickbacks
1
Kirtsaeng v. John Wiley & Sons
1
Kyle Bass
1
License Agreements
1
Licensing Rules
1
M&G Polymers v Tackett
1
Mandatory Victim's Restitution Act
1
Material Nonpublic Information
1
Medical Expenses
1
Merck
1
Misrepresentation
1
Montanile v Board of Trustees
1
Morgan Stanley
1
Motion for Summary Judgment
1
Motion to Compel
1
Mount Holly v Mt. Holly Citizens in Action
1
Mylan Pharmaceuticals
1
Nike
1
NLRB
1
No-Action Letters
1
Notice of Appeal
1
Notice Provisions
1
Obviousness
1
On-Sale Bar
1
Patent Exhaustion
1
Patent Expiration
1
Patent Invalidity
1
Patent-Eligible Subject Matter
1
Pay-For-Delay
1
Pensions
1
Pfizer
1
Physicians
1
Plan Participants
1
Prior Art
1
Public Use
1
Purple Book
1
Qualified Settlement Funds
1
Qui Tam
1
Reasonable Reliance Claims
1
Relators
1
Remedies
1
Renewal Fees
1
Retaliation
1
Reverse Payment Settlement Agreements
1
Ripeness
1
Rule 10b-5
1
Rule 23(b)(3)
1
Rule 23(f)
1
Rule 26
1
Same-Sex Marriage
1
Samsung
1
Scienter
1
Scope of Discovery Requests
1
Sealed Records
1
Section 220 Request
1
Sham Litigation Exception
1
Shareholder Litigation
1
Sherman Act
1
SLUSA
1
Standing
1
Stark Law
1
State Law Claims
1
Statutory Interpretation
1
Stipulations
1
Supervisors
1
Trademark Registration
1
TRICARE
1
TRO
1
UBS
1
UCC
1
UK
1
UK Patents Act
1
US v Windsor
1
USPTO
1
UT Southwestern Medical v Nassar
1
Vance v. Ball State University
1
Whistleblowers
1
Yard Man